Coleman Mark sold AXSM
June 2, 2026 · Form 4 insider transaction
Coleman Mark sold 5,537 shares of Axsome Therapeutics, Inc. at $223.39 per share, a transaction worth $1.24M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,537
Price
$223.39
Total value
$1.24M
InsiderColeman Mark
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 2, 2026
Filing dateJune 2, 2026
Shares owned after29,603
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the sale of underlying shares of previously exercised stock options.; Such transaction was pursuant to a pre-approved 10b5-1 plan.; Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $221.82 and $225.21.